Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyAmeriHealth precertification Prior Auth Policy Upd…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentAmeriHealthPolicy N/A

    Precertification requirements for elective services

    Customize your policy alerts

    Sign up for all AmeriHealth policy alerts

    Know when AmeriHealth releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines services and items that require precertification for elective, non-emergency care and notes that precertification does not guarantee coverage; applies to AmeriHealth members per plan benefits. A list of specific services, procedures, equipment, and genetic tests requiring precertification is provided.

    Policy Summary
    PayerAmeriHealth
    PolicyPrecertification requirements for elective services
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Next Review DateN/A
    Key ActionProviders must obtain precertification for listed elective/non-emergency services; precertification does not guarantee coverage and plan benefits determine coverage.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    20+service categories
    Multiplegenetic test groups
    Multipleexternal reviewers
    DetailedDME/prosthetics

    Services and Items Requiring Precertification

    Genetic testing categories

    Genetic tests requiring precertification include the following categories and examples:

    ALL of the following

    • Hereditary cancer syndromes

      • BRCA gene testing (breast and ovarian cancer syndrome)
      • Lynch syndrome gene testing
      • Familial adenomatous polyposis gene testing
      • PTEN gene testing (Cowden syndrome)
      • General cancer type panels (such as colon, breast, or neuroendocrine cancers)

    Codes Related to Precertification

    Precertification code list (referenced)mixed
    Refer to published medical code list on Medical Policy Portal for services requiring precertification.
    Genetic test procedure codes requiring precertificationCPTCovered
    81400-81408Non-specific molecular pathology procedure codes for genetic testing (CPT range)
    81479Unlisted molecular pathology procedure code
    81599Unlisted proprietary laboratory analysis code
    84999Unlisted chemistry procedure code

    Precertification Actions, Reviewers, and Notes for Providers

    Prior Authorization

    Precertification required for elective/non-emergency services

    Services that require precertification This applies to services performed on an elective, non-emergency basis. Because a service or item is subject to precertification, it does not guarantee coverage. The terms and conditions of your benefit plan must be reviewed to determine if any of these services or items are excluded. For your reference, we have published a list of medical codes for services that require precertification, which is available on our Medical Policy Portal for commercial and Medicare Advantage members.

    Note

    External reviewer: Carelon (AIM)

    Day rehabilitation programs Elective (non-emergency) ground, air, and sea ambulance transportation

    • † Precertification performed by Carelon Medical Benefits Management (formerly AIM Specialty Health), an independent company.
    • Precertification review benefit varies based on decision by member's employer group.

    Definitions and Scope Notes

    Precertification definition
    DefinitionPrecertification applies to services and items performed on an elective, non-emergency basis; completion of precertification does not guarantee coverage — benefit plan terms determine exclusions.
    ApplicabilityApplies to services and items listed in the document (inpatient, radiology, DME, genetic tests, specialty drugs, etc.).
    Coverage noteBecause an item is subject to precertification, plan terms and exclusions must be reviewed to determine actual coverage.
    External precertification review
    Third-party reviewersCertain precertification reviews are performed by independent reviewers such as Carelon Medical Benefits Management (formerly AIM), CareCore/eviCore, and Tango.
    Benefit variability
    Policy Summary
    PayerAmeriHealth
    PolicyPrecertification requirements for elective services
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Next Review DateN/A
    Key ActionProviders must obtain precertification for listed elective/non-emergency services; precertification does not guarantee coverage and plan benefits determine coverage.
    SourceLink
    On This Page
    Services and Items Requiring PrecertificationCodes Related to PrecertificationPrecertification Actions, Reviewers, and Notes for ProvidersDefinitions and Scope Notes
  1. Hereditary heart diseases

    • Long QT syndrome gene testing
    • Aortic dilation or aneurysm syndrome testing (includes Marfan syndrome)
  2. Other full gene analysis testing

    • Cystic fibrosis full gene sequencing and deletion/duplication analysis
    • PMP22 full gene sequencing and deletion/duplication analysis (Charcot-Marie-Tooth, hereditary neuropathy)
  3. Tests for many genetic disorders simultaneously

    • Expanded carrier screening panels (e.g., Carrier Status DNA Insight®, Counsyl Family Prep Screen, Pan-Ethnic Carrier Screening)
    • Hearing loss panels
    • Intellectual disability panels
    • Noonan spectrum disorders panels
  4. Specialty oncology tests

    • Cancer gene expression or protein signature tests (e.g., OncotypeDX®, MammaPrint®, Afirma®, Prosigna®, HeproDX™)
    • Tumor molecular profiling (e.g., FoundationOne®, neoTYPE™, OncoPlexDx®)
    • Tissue of origin testing (for cancer of unknown primary)
    • PCA3 testing for prostate cancer
  5. Pharmacogenomic tests

    • Cytochrome P450 metabolism gene testing (CYP2D6, CYP2C9, CYP2C19)
    • Specialized drug response gene panels (e.g., Assurex GeneSight®, GeneTrait, Genecept®)
    • Warfarin response testing
    • MGMT methylation analysis for glioblastoma
  6. Other specialty tests

    • Coronary artery disease risk testing (e.g., CorusCAD®, CardioIQ®, APOE, ACE, KIF6)
    • Heart disease risk testing (e.g., CorusCAD®, CardioIQ®, APOE, ACE, KIF6, MTHFR)
  7. Genome-wide tests

    • Microarray studies
    • Whole exome testing
    • Whole genome testing
    • Mitochondrial genome or nuclear testing
  8. ANY genetic test billed with CPT codes 81400-81408 or unlisted codes 81479, 81599, 84999 requires precertification review
  9. Specialty drug categories and agents

    Specialty drugs and biologics requiring precertification for commercial members (partial list):

    ALL of the following

    • Alzheimer's Disease agents

      • Kisunla™ §
      • Leqembi™ §
    • Amyotrophic lateral sclerosis agents

      • debamestrocel*
      • Qalsody ®§
    • Antineoplastic agents

      • Abraxane ®
      • Adcetris ®
      • Adstiladrin ®
      • Alymsys ® (except for ophthalmological conditions)
      • Anktiva ®
      • Avastin ® (except for ophthalmological conditions)
      • Avzivi ®
      • Azedra ®†
      • Bizengri ®
      • Blincyto ®
      • Columvi
      • Cyramza ®
      • Darzalex ®
    • Anti PD-1/PD-L1 human monoclonal antibodies

      • Bavencio ®
      • balstilimab*
      • camrelizumab*
      • Imfinzi™
      • Jemperli
      • Keytruda ®
    • Bone-modifying agents

      • Aukelso ®
      • Bildyos ®
      • Bilprevda ®
      • Bomyntra
      • Bosaya ®
      • Connexence ®
      • Evenity ®
    • Botulinum toxin agents

      • Botox ®
    • CAR-T therapies

      • Abecma™
      • Breyanzi ®
      • Carvykti™
      • Kymriah™
    • Duchenne Muscular Dystrophy agents

      • Amondys 45 §
      • Exondys 51 §
      • Viltepso ®§
      • Vyondys 53 §
    • Endocrine/metabolic agents

      • Acthar H.P. ®
      • Lutathera ®†
      • Sandostatin ® LAR
    • Enzyme replacement agents

      • Adzynma
      • Aldurazyme ®
      • Brineura™
      • Cerezyme ®
    • Gene replacement/gene editing therapies

      • Casgevy ®
      • Elevidys™
      • Hemgenix ®
    • Hyaluronate acid products

      • Cingal ®
      • Durolane ®
      • Euflexxa™
    • All listed brands and their generic equivalents or biosimilars require precertification; list is subject to change and applies to commercial plans.

    Drugs and therapeutic classes requiring precertification or special handling

    This section enumerates therapeutic categories and specific drugs subject to precertification or special handling:

    ALL of the following

    • Gene replacement / gene editing therapies**

      • Casgevy ®
      • clemidsogene lanparvovec*
      • Elevidys™
      • etuvetidigene autotemcel*
      • Hemgenix ®
    • Hyaluronate acid products

      • Cingal ®
      • Durolane ®
      • Euflexxa™
      • Gel-One ®
      • Gelsyn-3™
    • Immunological agents

      • Actemra ® IV
      • Avsola™
      • Benlysta ® IV
      • Cosentyx ® IV
      • Entyvio™ IV
    • Multiple sclerosis agents**

      • Briumvi™
      • Lemtrada ®
      • Ocrevus™
    • Myasthenia gravis agents**

      • Imaavy ®
      • Vyvgart ®
    • Neutropenia agents

      • Fylnetra™
      • Granix ®
      • Neupogen ®
      • Udenyca ®
    • Ophthalmic agents

      • Ahzantive ®
      • Beovu ®
      • Eylea ®
      • Lucentis ®
    • Pulmonary arterial hypertension agents**

      • Flolan ®
      • Remodulin ®
      • Tyvaso ®
    • Respiratory agents

      • Cinqair ®
      • Synagis
      • Xolair ®
    • Respiratory enzymes (alpha-1 antitrypsin)**

      • Aralast
      • Glassia™
      • Prolastin ®
    • Tumor-infiltrating lymphocyte (TIL) and T-cell Therapies **

      • Amtagvi™
      • Imdelltra™
      • linvoseltamab*
    • Miscellaneous therapeutic agents

      • Adakveo ®
      • Amvuttra™
      • Crysvita ®
      • Enjaymo™
      • Evkeeza™
    • Precertification applies to all drugs classified under each header, including unlisted brand/generic names and biosimilars; precertification review for items marked ** is provided by eviCore (CareCore). Some listed agents or classes may be subject to group-level exclusions.

    Note

    External reviewer: eviCore / CareCore

    Medical foods Hyperbaric oxygen therapy Proton beam therapy

    • * Precertification review is provided by CareCore National, LLC d/b/a eviCore healthcare (eviCore), an independent company.
    • Precertification review benefit varies based on decision by member's employer group.
    Note

    External reviewer: Tango (PA Medicare lines)

    Home-care services

    • Precertification review for PA Medicare lines of business is provided by Tango, an independent company.
    Prior Authorization

    Precertification: non-specific genetic test procedure codes

    ANY genetic test that will be billed with a non-specific procedure code

    • Billed with CPT codes 81400 - 81408.
    • Billed with an unlisted code: 81479, 81599, 84999
    • * Precertification review is provided by CareCore National, LLC d/b/a eviCore healthcare (eviCore), an independent company.
    • Precertification review benefit varies based on decision by member's employer group.
    Note

    Precertification vendor and benefit variability

    Precertification review vendor and benefit note

    • Precertification review for many services and drugs is provided by CareCore National, LLC d/b/a eviCore healthcare (eviCore), an independent company.
    • Precertification review benefit varies based on decision by member's employer group; employers may have exclusions or different terms.
    Prior Authorization

    Precertification requirement and reviewer

    Certain specialty drugs and all listed gene replacement/gene editing therapies, hyaluronate acid products, and other specified pharmaceuticals require precertification.

    • eviCore provides precertification review for the listed drugs and therapies.
    • Precertification is required for the listed drugs; benefits and any exclusions depend on the member's employer group.
    Precertification review benefit may vary based on the decision of the member's employer group.
    Line-of-business noteTango performs precertification review for PA Medicare lines of business.
    Precertification review provided by CareCore/eviCore
    ReviewerPrecertification review for certain genetic tests and specialty drugs is provided by CareCore National, LLC d/b/a eviCore healthcare (eviCore).
    Benefit variabilityBenefit for precertification review varies based on the member's employer group decision.
    ScopeApplies to genetic tests billed with non-specific procedure codes and to specialty drug classes as indicated in the list.
    Specialty drugs list applicability
    Plan applicabilitySpecialty drugs listed require precertification for members enrolled in commercial plans.
    Medicare Advantage membersInformation for Medicare Advantage precertification requirements is available on the Medicare Advantage website (separate resources).
    InclusionsAll listed brands and their generic equivalents or biosimilars require precertification; list is subject to change.
    Precertification scope
    Inclusive scopePrecertification requirement applies to all drugs that can be classified under the header, including any unlisted brand or generic names or biosimilars.
    New approvalsIncludes new drugs approved by the FDA in that class during the benefit year.
    ExamplesApplies to categories such as hyaluronate acid products and other therapeutic class headers listed in the document.
    Precertification reviewer and benefit variability
    Reviewer identityeviCore (CareCore National, LLC d/b/a eviCore healthcare) provides precertification review for drugs and certain genetic tests.
    Benefit variabilityWhether precertification review is a covered benefit varies by the employer group's decision.
    Applies to codeseviCore review applies to genetic tests billed with non-specific CPT codes noted in the policy as requiring precertification.
    Biosimilar precertification
    Biosimilar inclusionPrecertification requirements apply to all FDA-approved biosimilars to the reference product.
    Brand/generic parityBiosimilars are treated equivalently to the reference product for precertification purposes (included under the same header).
    TimingApplies during the benefit year including newly approved biosimilars in that class.
    Group-level exclusions
    Group-level exclusionsSome commercial groups or members have a benefit exclusion for these drugs, meaning precertification may not result in coverage where excluded.
    Verify benefitsProviders must verify member-specific benefits and exclusions with the employer group or plan before assuming coverage.
    List subject to changeThe specialty drug list and exclusions are subject to change and should be checked against current plan resources.